Brief Note on Multiple Sclerosis
Multiple sclerosis (MS) is the most common potentially disabling disease affecting people
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Multiple sclerosis (MS) is the most common potentially disabling disease affecting people
Background: Early diagnosis of multiple sclerosis (MS) can lead to preventive treatment and a favorable prognosis. Cervical spinal cord matter that appears normal on conventional MR images may be detected ... pinpoint…
Objective:This study explores the lived experience in their working lives of
stem cell transplantation (HSCT) and disease-modifying therapies (DMTs) for the treatment of relapsing-remitting multiple sclerosis (RRMS). Importance Hematopoietic stem cell transplantation (HSCT) represents a…
this study was to compare the efficacy of natalizumab and fingolimod in relapsing-remitting multiple sclerosis patients in real-world clinical setting. Methods: We enrolled 391 patients starting either natalizumab…
Havrdova E, et al. A randomized, placebo-controlled tral of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006; 354:899-910 2. Bloomgren G, Richman S, Hotermans ... Cohan SL, Moses H, Calkwood J, et al…
directly target glial cells. Fingolimod is a widely used treatment for highly active relapsing-remitting multiple sclerosis. Objective: Here we investigate effects of fingolimod on expression of whether pre-treatment…
evolution of multiple sclerosis there are some clinical types: clinical isolated syndrome, relapsing-remitting multiple sclerosis, primary progressive multiple sclerosis, secondary progressive multiple sclerosis…
results of high dose intravenous monthly pulse CYC on patients with worsening relapsing-remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS) were evaluated. Methods: Fifty-six patients
took place in Sofia, Bulgaria with 18 participants â?? men, clinically diagnosed with relapsing-remitting multiple sclerosis with duration over five years and more than 4 crises. We used
Abstract Objective: To explore the abnormal intrinsic functional hubs in relapsing-remitting multiple sclerosis (RRMS) using degree centrality approach and their relationships with clinical features. Methods: Total of…
mutations of mitochondrial DNA. Mitochondrial genetic variations may influence susceptibility to develop multiple sclerosis and neuromyelitis optica. In order to explore the possible correlation between mitochondrial…
during the next pregnancy after abortion. Interferon beta-1a for the treatment of relapsing-remitting multiple sclerosis was stopped before pregnancy. During pregnancy only subcutaneous immunoglobulin was administered…
safety of these drugs was assessed in Mexican patients under treatment for relapsing-remitting multiple sclerosis (RRMS). A parallel, multicenter, prospective and comparative study was carried out. Fifty patients with
patient suffered acute myelitis. Our patient represents a rare case of late onset Relapsing-Remitting Multiple Sclerosis (RRMS) presenting with an eight-and-a-half-syndrome. Apart from the clinical
Herein, we present a case of a 39-year-old female patient with relapsing-remitting multiple sclerosis (MS), who was receiving immunomodulatory therapy and subsequently developed severe PAH. We presume
Features of headache attacks during relapse and remission phases among patients with relapsing-remitting multiple sclerosis, (A) Types of headache, (B) severity of headache, (C) quality of headache, (D) location
Introduction: Multiple Sclerosis (MS) is a relapsing or progressive neurological disease with an unknown etiology. MS has a negative impact on both physical and psychological well-being ... Methods: The study took place…
Multiple sclerosis (MS) is an autoimmune disease, in which due to defective functions of CD4+ CD25+ regulatory T cells, autoreactive T lymphocytes promotes neuroaxonal degeneration in central nervous system. Tregs…
probiotics supplementation on disease progression, depression, general health, and anthropometric measurements in relapsing-remitting multiple sclerosis patients: A systematic review and meta-analysis of clinical…
signal transduction pathways. More recently DMF is registered as systemic therapy for relapsing-remitting multiple sclerosis
inhibited experimental autoimmune encephalomyelitis mediated by functional FoxA1 and PDL1. In patients with relapsing-remitting multiple sclerosis, response to IFN-β-treatment was associated with expansion of…
abnormalities in fractional anisotropy (FA) may be involved in cognitive dysfunctions in Relapsing-Remitting (RR)-Multiple Sclerosis (MS). Objective: The aim of our study was to investigate the microstructural integrity
been reportable to scale back the speed of relapses in relapsing-remitting disseminated multiple sclerosis by or so common fraction over a biennial amount. Fingolimod was shown to be effective
For authors and organisers
Find the right journal for your paper and submit your manuscript.